MedPath

Influence of Vitamin D on Vascular Function in Adolescents and Young Adults With Type 1 Diabetes

Phase 2
Completed
Conditions
Diabetes Mellitus, Type 1
Interventions
Dietary Supplement: Vitamin D
Registration Number
NCT01103817
Lead Sponsor
The Hospital for Sick Children
Brief Summary

The purpose of this study is to study the role of low vitamin D levels on the health of blood vessels or vascular function in adolescents and young adults with type 1 diabetes.

Detailed Description

Vitamin D deficiency is known to be common in patients with type 1 diabetes. Studies in adults have shown that vitamin D deficiency is associated with cardiovascular events such as stroke, myocardial infarction and peripheral arterial disease. However, the impact of this deficiency on vascular health in adolescents with diabetes has not been examined. Furthermore given that endothelial dysfunction is reversible, early detection of this process may have therapeutic and prognostic implications in this population.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
33
Inclusion Criteria
  1. Diagnosed with type 1 diabetes, according to Canadian Diabetes Association guidelines
  2. Diagnosed with type 1 diabetes for at least 2 years
  3. Between the ages of 12 and 18 years
Exclusion Criteria
  1. Previous organ transplantation
  2. Diagnosed with familial hypercholesterolemia
  3. Active smoker
  4. Receiving lipid lowering medications
  5. Receiving anti hypertensive medication
  6. Significant chronic medical illness, including granulomatous disease
  7. History of hypertension
  8. BMI >95%tile
  9. Known renal failure
  10. HbA1c greater than 12% on two successive occasions
  11. Known peripheral vascular disease
  12. Known hypercalcemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Vitamin D DeficientVitamin DDeficient is defined as a 25 OH vitamin D level ≤ 37.5 nmol/l. This group will receive Vitamin D. Subjects will have fasting bloodwork done. Other study measurements to be taken include: height and weight, stage of puberty, blood pressure, vitamin D and calcium intake information, diabetes risk information, demographic information and spot urine sample. We will also do a non-invasive test called a "PAT" or 'peripheral arterial tonometry' to look at the health of your blood vessels.
Primary Outcome Measures
NameTimeMethod
Change in Endothelial Function after Treatment with Vitamin DBaseline, 3 or 6 months

We will measure the change in endothelial function from baseline in the children that were vitamin D deficient. This measurement will be done once the child has become vitamin D sufficient.

Vitamin D status will be assessed at 3 months. If the levels remain deficient treatment would continue for another 3 months, with repeat testing at 6 months.

Endothelial function will be assessed by peripheral arterial tonometry (PAT) which measures the elasticity of the arteries.

Comparison of Endothelial FunctionBaseline

We will compare endothelial function in adolescents with type 1 diabetes divided into 2 groups on the basis of vitamin D status (deficient and sufficient).

Endothelial function will be assessed by peripheral arterial tonometry (PAT) which measures the elasticity of the arteries.

Secondary Outcome Measures
NameTimeMethod
Comparison of Urinary Albumin/Creatinine RatioBaseline

We will compare the urinary albumin/creatinine ratio in adolescents with type 1 diabetes divided into 2 groups on the basis of vitamin D status (deficient and sufficient).

Monitoring of Vitamin D Levels in Vitamin D deficient subjects2-3 months

At a vist to take place at 2-3 months, the Vitamin D deficient sujects will undergo blood sampling for 25 hydroxyvitamin D levels to ensure appropriate treatment with D Drops to normalize 25 OH vitamin D levels greater than 50 nmol/L.

Comparison of Systemic Blood PressureBaseline

We will compare endothelial function in adolescents with type 1 diabetes divided into 2 groups on the basis of vitamin D status (deficient and sufficient).

Monitoring of Calcium Creatine Ratio in Vitamin D deficient subjects2-3 months

At a vist to take place at 2-3 months, the Vitamin D deficient sujects will have a urine assessment of spot calcium creatinine ratio to ensure that hypercalcemia (calcium/ creatinine ratio greater than 0.7) is not present.

Trial Locations

Locations (1)

The Hospital for Sick Children

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath